Clovis Oncology's 45% Pre-Market Surge, Explained
June 19, 2017 at 08:21 AM EDT
Shares of Clovis Oncology Inc (NASDAQ: CLVS), a biopharmaceutical company that develops an ovarian cancer drug called Rubraca ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.